Navigation Links
Galaxy Single Piece PMMA Lens with UV Absorber

ProductsGalaxy Single Piece PMMA Lens with UV Absorber
Company Ellis Ophthalmic Technologies, Inc.
Item Galaxy Single Piece PMMA Lens with UV Absorber
Features Inquire
Description Galaxy Single Piece PMMA Lens with UV Absorber.
Info Ellis Ophthalmic Technologies, Inc.
Customer Service: (718) 656-7390

Related medicine products :

1. Galaxy Digital Imaging Console
2. Single Skin Hook
3. Single Tantalum Clip (50 Style)
4. Single Beam
5. Single Plate Molteno Implant (S1)
6. Pressure Ridge Single Plate Molteno Implant (D1)
7. Cottle Single Hook
8. Goldman Single Hook
9. Joseph Single Hook
10. Kleinert-Kutz Single Skin Hook
11. Ocular Single Mirror Gonio
...lace the eyeglasses in the EZ Meter and press the ...display the measurement results on its large color...a printout makes this the ideal instrument for use...tion to being extremely easy-to-use, the EZ-200 is...
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump.
Stryker Endoscopy has combined a standardized pressurizing system with an advanced hand piece design that is lightweight and compact in order to streamline laparoscopic procedures.
Developed specifically to disintegrate renal and ureteral stones, the LithoDiamond features state-of-the-art technology in a compact design to deliver an exceptionally efficient and affordable lithot
Medicine Products:
(Date:9/5/2008)...Expert Pathologists Discuss the Latest Development... NORTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/...on point. Molecular testing and the promise,of per...e treated. Digital,slides and other imaging techno...College of American Pathologists is taking a leade...
(Date:9/5/2008)...tional Survey From American Humane Shows Public Re...ricane Gustav Pet Evacuation Efforts Confirm ...pt. 5 /PRNewswire/ -- A 2007 survey by the America...icans would refuse rescue,assistance if it meant l...anna, Ike and Josephine moving towards the U.S. co...
(Date:9/5/2008)...Advocates call on John McCain to commit to develop...IS and ST. PAUL, Minn., Sep. 5 /PRNewswire-USNewsw...ed last night with no mention of the,domestic AIDS...ference to,the epidemic overseas. Neither Presiden...l nominee Gov. Sarah Palin mentioned AIDS in their...
(Date:9/5/2008)...The National Institute of Diabetes and Digestive a...nstitutes of Health (NIH), announces awards to eig...ive studies of urologic chronic pelvic pain disord...rostate. The total research investment for the fiv...ion. , "The launch of this novel research effort...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3
...fret or blame all those people who had been tellin...ays an important part for bone strength but is not...utrients as well. // As per a recent study which i... funded by the US government “Calcium and vitamin ...
... could be a significant predictor for periodontal ...researchers from University at Buffalo. Furthermor...nt of age, sex, race, ethnic background or smoking...dontal disease and obesity could be due to the und...
...ralian lady patient, has become the first receipen...ich depends on seaweed. She is believed to be the ...ansplant procedure, an experiment that will not ne...art was injected with about 200,000 pancreatic ce...
...s is a problem where people are plagued all round ... Jan Dawson suffered from it since she was three. ...oldiers marching up and down a metal spiral stairc...s still persist and it never goes away. She being ...
Other Medicine News:Health News:Calcium in isolation no good for maintaining bone integrity 2Health News:Tinnitus: a problem which is still ambiguous 2
(Date:9/3/2008)...estion Asked. Wrong Children Studied. Wrong,Conclu...Newswire/ -- A Centers for Disease,Control and Pre... no link,between the MMR vaccine and autism. The N...oes nothing to dispel the growing public concern o... questions concerning design,and methodology., Fo...
(Date:9/3/2008)...w up results from chronically infected Hepatitis C...a obtained earlier in 2008, - Study is the first... antiviral effect of therapeutic Hepatitis ...support move into a second generation, vaccine fo...through TLR activati...
(Date:9/3/2008)..., Sept. 3 /- Panacea Pharmaceuticals,...Number 7,413,737 covering,antibodies against human...,proprietary human cancer biomarker and therapeuti...boration with the Massachusetts Institute of,Techn...ights to this patent,for development of human canc...
(Date:9/3/2008)...perations, Updates Zingo Launch Progress and Adlea... Conference Call Today at 11:30 am ET...e-FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) ann...rations to focus on commercial and late-stage prod...specialty pharmaceutical pain management,company. ...
Breaking Medicine Technology:CDC Misses Target With Flawed MMR/Autism Study 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Bright Medical Associates Selects InteGreat EHR for Ease of Use 7934 1Bright Medical Associates Selects InteGreat EHR for Ease of Use 7934 2Bright Medical Associates Selects InteGreat EHR for Ease of Use 7934 3Emageon Names Chris E Perkins as Chief Operating Officer 7930 1Emageon Names Chris E Perkins as Chief Operating Officer 7930 2New study shows worlds protected areas threatened by climate change 7926 1New study shows worlds protected areas threatened by climate change 7926 2American Chemical Societys Weekly PressPac Dec 5 2007 1515 1American Chemical Societys Weekly PressPac Dec 5 2007 1515 2American Chemical Societys Weekly PressPac Dec 5 2007 1515 3American Chemical Societys Weekly PressPac Dec 5 2007 1515 4American Chemical Societys Weekly PressPac Dec 5 2007 1515 5American Chemical Societys Weekly PressPac Dec 5 2007 1515 6American Chemical Societys Weekly PressPac Dec 5 2007 1515 7American Chemical Societys Weekly PressPac Dec 5 2007 1515 8American Chemical Societys Weekly PressPac Dec 5 2007 1515 9
...s--(BUSINESS WIRE)--Apr 3, 2007 - Repros,Therapeut...f a U.S.,Phase 2 study of Proellex(TM), an oral dr...fibroids. This study suggests that,treatment with ...cant improvement in symptoms associated with uteri...y Details and Results , This 12 week, double-blind...
...O, Calif., April 03, 2007,/PRNewswire-FirstCall/ -...d results from its second multi-center Phase 2 tri... evaluated escalating doses,of the immunotherapy i...rostate cancer (HRPC). Additional follow-up of,the...ble to that,being employed in the company,s ongoin...
Other Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3